Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANTER: Sodium Bicarbonate vs Saline for CIN Prevention in TAVI
NCT03121053Phase 4Unknown
- Start
- Oct 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium bicarbonate in contrast-induced nephropathy (CIN) (2 arms). Primary endpoints: Contrast induced nephropathy at Day 3 and Acute heart failure due to volume expansion at Day 3. Status: unknown.
02
Drugs
sodium bicarbonate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT03121053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03121053.